Author Archive

BDSI ENDP GEVA ICNY OPHT updates

Feb 24, 2015 No Comments

Latest updates to the Company Pipeline Database for Monday February 23, 2015. Refer to the FDA Calendar for upcoming catalysts: Ticker Price Drug Indication Stage Link Text Updated BDSI 14.63 BEMA Buprenorphine Management of pain severe enough to require daily, around-the-clock, long-term opioid treatment for which alternative treatment options are inadequate PDUFA Announced Dec 23 […]

Read more

Updates for week ending February 20

Feb 20, 2015 No Comments

Latest updates to the Company Pipeline Database for week ending February 20, 2015. Refer to the FDA Calendar for upcoming catalysts: Ticker Price Drug Indication Stage Link Text Updated AGIO 106.30 AG-348 Pyruvate kinase deficiency Phase 2 Phase 2 trial to be initiated 1H 2015 2/21/2015 ARIA 8.06 Brigatinib – ALTA trial Anaplastic lymphoma kinase […]

Read more

Pipeline updates for ADHD BIOD CYTK GNCA HZNP INCY IRWD MDWD PTN VSAR

Feb 14, 2015 No Comments

Latest updates to the Company Pipeline Database for February 12-13, 2015. Refer to the FDA Calendar for upcoming catalysts: Ticker Price Drug Indication Stage Link Text Updated ADHD 6.92 MDX (Metadoxine Extended Release (MG01CI)) Fragile X Syndrome Phase 2b Phase 2b enrolment due to be completed 1Q 2015. Data due 2Q 2015 2/14/2015 ADHD 6.92 […]

Read more

Latest updates for TTHI NBIX OHRP GALE KMDA AMAG ANIK AMGN ANTH RGLS LJPC SGEN SGMO

Feb 12, 2015 No Comments

Latest updates to the Company Pipeline Database for February 9-11, 2015. Refer to the FDA Calendar for upcoming catalysts: Ticker Price Drug Indication Stage Link Text Updated AMAG 40.05 Makena – single-dose (1 mL) vial Reduce the risk of preterm birth in women with a singleton pregnancy PDUFA FDA decision due 2Q 2015 2/12/2015 AMGN […]

Read more

Updates for SNTA BOTA DERM PTLA

Feb 06, 2015 No Comments

Latest updates to the Company Pipeline Database for February 5, 2015. Refer to the FDA Calendar for upcoming catalysts: Ticker Price Drug Indication Stage Link Text Updated BOTA 2.48 Vapendavir Human rhinovirus (HRV) Phase 2b Phase 2b top-line data due mid 2016 2/6/2015 DERM 15.73 DRM04 Primary axillary hyperhidrosis Phase 2b Phase 3 to be […]

Read more

CANF data due by end of March. IMMU lupus data due 1H + pipeline updates for GWPH BIND IRWD MSTX

Feb 05, 2015 No Comments

Latest updates to the Company Pipeline Database for February 4, 2015. Refer to the FDA Calendar for upcoming catalysts: Ticker Price Drug Indication Stage Link Text Updated BIND 6.34 BIND-014 Cancer – KRAS mutant Non-small cell lung cancer (NSCLC) Phase 2 Preliminary data due 2H 2015 2/5/2015 BIND 6.34 BIND-014 Cancer – Squamous histology NSCLC […]

Read more

Updates for ASPX ISIS CTIC MRNS + CPXX added to the database.

Feb 04, 2015 No Comments

Latest updates to the Company Pipeline Database for February 3, 2015. Refer to the FDA Calendar for upcoming catalysts: Ticker Price Drug Indication Stage Link Text Updated ASPX 58.22 SD-809 Tardive Dyskinesia (TD) Phase 2/3 Phase 2b enrolment completed early Feb 2015. Topline data due mid 2015. Data from Phase 3 trial due 2016 2/4/2015 […]

Read more

ARDX disappoints with Phase 2b trial. RPRX files NDA + AQXP CPRX CVM EVOK FLXN HTBX INSV ONTX PLX

Feb 03, 2015 No Comments

Latest updates to the Company Pipeline Database for February 2, 2015. Refer to the FDA Calendar for upcoming catalysts: Ticker Price Drug Indication Stage Link Text Updated AQXP 11.27 AQX-1125 FLAGSHIP Chronic obstructive pulmonary disease (COPD) Phase 2 Phase 2 enrolment completed early Feb 2015. Data due mid 2015 2/3/2015 ARDX 19.25 Tenapanor Hyperphosphatemia in […]

Read more

13 Recent IPOs added to BioPharmCatalyst: JUNO TCON ONCE NEOT ASND BLCM CHRS XENE ZSAN XENE HSGX FGEN NDRM

Jan 31, 2015 No Comments

13 recent biotech IPOs up until January 30, 2015 have been added to the Company Pipeline Database. Companies with upcoming clinical data releases have also been added to the FDA Calendar: Many thanks to @AndyBiotech on twitter for keeping up with the IPOs. Ticker Price Drug Indication Stage Link Text Updated ASND 19.83 TransCon Growth […]

Read more

ZGNX FDA Approval + updates for APPY CORT IMGN PCYC RDUS SGYP VCEL VRTX

Jan 31, 2015 No Comments

Expect updates to be streaming in thick and fast over the next two weeks when most small-mid cap companies report 4Q 2014 results. Latest updates to the Company Pipeline Database for January 28-30, 2015. Refer to the FDA Calendar for upcoming catalysts: Ticker Price Drug Indication Stage Link Text Updated APPY 0.50 Appy1 Acute appendicitis […]

Read more

AMGN additions to the Pipeline Database and FDA Calendar

Jan 28, 2015 No Comments

Latest updates to the Company Pipeline Database for January 27, 2015. Refer to the FDA Calendar for upcoming catalysts: Ticker Price Drug Indication Stage Link Text Updated AMGN 158.89 Blinatumomab Acute Lymphoblastic Leukemia PDUFA PDUFA May 19, 2015. Priority review 1/28/2015 AMGN 158.89 ABP 501 (adalimumab) Moderate-to-severe rheumatoid arthritis Phase 3 Phase 3 data due […]

Read more